Cellular Localization and Antiproliferative Effect of Peptides Discovered from a Functional Screen of a Retrovirally Delivered Random Peptide Library  by Hitoshi, Yasumichi et al.
Chemistry & Biology, Vol. 10, 975–987, October, 2003, 2003 Elsevier Science Ltd. All rights reserved. DOI 10.1016/j .chembiol .2003.09.009
Cellular Localization and Antiproliferative Effect
of Peptides Discovered from a Functional Screen
of a Retrovirally Delivered Random Peptide Library
domly generated peptide sequences represent a vast
source of biomolecular structures that can uniquely af-
fect cell-signaling pathways. Large peptide libraries can
be efficiently expressed in mammalian cells as free enti-
ties or covalently linked to reporter proteins that act as
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Retroviruses are ideal delivery vehicles for the stable
expression of peptides in mammalian cells. RetrovirusesSummary
can be produced at high titer, infect dividing cells with
high efficiency [1, 2], and exhibit diverse tropism. Fur-We have generated a random peptide library fused to
thermore, because retroviral vectors are stably inte-GFP in a retroviral vector system and used this library
grated into the host cell genome, the cognate peptideto screen for peptides inhibiting tumor cell growth.
sequence can be readily retrieved and transferred toFour unique peptide sequences were isolated that ex-
a naı¨ve cell population once a specific phenotype ishibited antiproliferative effects and that specifically
identified. Because of these versatile characteristics,localized to the plasma membrane and cytoplasmic
retrovirally mediated functional screening approachesgranular compartments. Mutational analysis revealed
have been utilized for identification of physiologicallycritical residues in each peptide sequence and demon-
relevant regulators of cell signaling in normal and dis-strated a correlation between peptide subcellular lo-
eased cells [3–8]. Inducible expression systems allowcalization and antiproliferative activity. Synthetic ana-
phenotypes in both the presence and absence of geneticlogs of the peptides with poly-lysine internalization
effector expression to be directly compared within thesequences, but not loss-of-function mutant peptides,
same cells. Incorporation of inducible systems in func-competed for subcellular localization of the parent
tional screens can provide a strong advantage, espe-GFP-fused peptides. The synthetic peptides exhibited
cially in identification of cell cycle regulators. Amongdose-dependent antiproliferative effects in tumor cells,
several inducible gene expression systems, the tetracy-while mutant peptides had no effect. Our screening
cline (tet)-regulatable system has been successfully in-approach using retrovirally expressed intracellular pep-
corporated into several mammalian expression systemstides enables identification of unique sequences with
including those mediated by retroviruses.a specific biological function and with potential as
Individual peptides or peptide libraries can be ex-therapeutics.
pressed as either free entities or as covalently linked
fusions with scaffolding peptides or proteins. While freeIntroduction
peptides are typically unstable in an intracellular envi-
ronment, expression of peptide-scaffold protein fusionsThe generation and screening of diverse sets of molecu-
can increase stability and intracellular concentration oflar structures is a central tenet of modern drug discov-
potentially phenotype-altering peptide sequences. Sev-ery. These molecules can bind specific sites on proteins,
eral protein scaffolds, including thioredoxin [9], greenaltering their normal function and causing a distinct cel-
fluorescent protein (GFP) [8, 10], and Staphylococcallular phenotype. An alternative approach that builds on
nuclease [11], have already been used for intracellularsimilar principles is intracellular expression of dominant
peptide display in yeast, bacteria, and mammalian cells.
genetic effectors. These effectors, exemplified by pep-
GFP in particular affords a significant advantage be-
tides or mutant proteins, can also bind and inhibit the
cause cellular localization and expression levels can be
normal function of specific proteins. Libraries of ran-
monitored based on its intrinsic fluorescence while the
scaffold itself has low toxicity, high stability (resulting in
*Correspondence: yhitoshi@rigel.com high peptide expression levels), and few specific known
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these functional genomic approaches is the identifica-Belgium.
tion of novel peptide inhibitors of cell proliferation. Alter-5 Present address: Institute for Molecular Biology, University of Oregon,
Eugene, Oregon 97403. ation of the expression and activity of cell proliferation
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regulators is common in a variety of human diseases based cell sorting, 1.1  105 cells were obtained and
plated for single-cell cloning in the presence of doxycy-such as cancer, cardiovascular disease, and psoriasis
where aberrant proliferation contributes to the pathol- cline (Dox) to suppress GFP-peptide expression. More
than 95% of tTA-mediated gene expression in A549.tTAogy of the illness. Cell proliferation is tightly regulated
by the activation and inactivation of an array of signaling cells was suppressed by 10 ng/ml Dox (data not shown).
The cells that did not grow in Dox containing mediaproteins. The endogenous activities of these signaling
pathway members can be blocked by disruption of their (peptide off) probably due to spontaneous arrest or the
effect of retrovirus insertion were eliminated during sin-protein-protein interactions and/or catalytic activities.
We have shown recently that intracellular expression of gle-cell cloning. Following careful observation, 4128 col-
onies were picked and analyzed for their growth in bothpeptides derived from the cell cycle inhibitor p21 can
mimic the proliferating cell nuclear antigen (PCNA) inter- Dox-containing (peptide expression off) and Dox-free
media (peptide expression on). Of these, 95 clones wereaction and phenotypic effects of the native protein [12].
Thus, small peptides constitute powerful tools for inhib- identified that showed both reduction of cell growth in
the absence of Dox and normal cell growth in the pres-iting intracellular signaling cascades and offer an alter-
native to conventional small molecule-based therapeu- ence of Dox. The peptide-encoding retroviral inserts
from these clones were amplified by PCR, recloned, andtics for the treatment of several diseases including cancer
[14–16]. transduced into naı¨ve A549.tTA cells to evaluate their
effect on cell proliferation with the DiI staining intensityWe have developed a screen for growth inhibition
that utilizes tet-inducible expression (tet-off system) of assay. Based on their ability to transfer phenotype, four
peptides, 35, 38, 40, and 41, were identified as signifi-a GFP-fused random peptide library. A strategy for se-
lection of cells exhibiting an arrested or growth-deficient cant inhibitors of cell proliferation in A549.tTA cells.
As shown in Figure 1B, the inserts recovered fromphenotype has been devised based on maintenance
of staining intensity following vital dye treatment and clones 35, 38, 40, and 41 encode 17-mer, 25-mer, 20-
mer, and 25-mer peptides, respectively. Peptides 35 andresistance to retroviral delivery of a cytotoxic gene. Pep-
tides identified by the screen exhibited unique cellular 40 have an additional amino acid sequence (RPVRP)
derived from the vector due to deletion of 1 nucleotidelocalization patterns and significant antiproliferative ef-
fects. Our screen for growth inhibitors using a GFP- in the randomized region of the peptides. BLAST search
analysis revealed that the four peptides do not havefused peptide library is a novel approach to identify and
validate several functional peptide inhibitors, which may more than 50% total identity to any known sequences,
indicating that the four peptides represent novel aminoprovide useful tools for understanding signaling path-
ways the treatment of various diseases including cancer. acid sequences.
Because the four peptides recovered in our functional
genetic screen were selected, in part, based upon the
Results fluorescence intensity of the cell tracker dye Dil, we utilized
this assay to confirm the effect of each peptide individu-
Intracellular Screening for ally on cell proliferation (Figure 2). Nondividing cells or
Antiproliferative Peptides slow growing cells remain DiI bright as a result of the
A dual selection scheme for the isolation of antiprolifera- decreased rate of cell division. Due to the efficiency of
tive peptides was developed that entailed (i) positive retroviral infection, transduction of A549.tTA cells with
selection for cells that fail to “dilute” the lipophilic cell viruses encoding the GFP-peptide results in a mixed
membrane staining dye, DiI, through successive rounds population of peptide-expressing (GFP positive) and un-
of cell division and (ii) negative selection of cycling cells infected cells (GFP negative). Thus, by FACS analysis,
by infection with retrovirally encoded diphtheria toxin  one can assess the effect of the peptide on proliferation
chain (DT- virus). Nondividing or slow growing cells, by comparing the DiI intensity distribution of the GFP-
which remained DiI bright were easily distinguished and positive population (gating on either the entire peak or
selected (without cell fixation) by fluorescence-acti- a subpopulation consisting of the highest expressors)
vated cell sorting (FACS) while the preferential suscepti- with that of the GFP-negative population in the same
bility of dividing cells to DT  virus infection (due to the sample.
requirement for nuclear envelope breakdown for effi- Negative controls, including destabilized GFP (dsGFP)
cient retroviral integration) efficiently eliminated cycling and GFP-peptide 10 (an inactive member of the library),
cells. A combination of these two selection methods showed no significant difference in the DiI fluorescence
was applied to a population of A549 cells expressing a intensity distribution between the GFP-positive and
GFP-fused peptide library to enrich for peptides that GFP-negative populations. (The very slight shift in DiI
cause an antiproliferative phenotype. The screening intensity for the highly GFP-positive subpopulation rela-
strategy is depicted schematically in Figure 1A. Briefly, tive to the GFP-negative population is likely due to mod-
4  108 A549.tTA cells were infected with the tet-induc- est intrinsic GFP toxicity.) As a positive control, we uti-
ible (tet-off) retroviral GFP-fused peptide library (TRA- lized GFP fused to the PCNA binding C-terminal peptide
GFP-C20 containing 1.1  109 independent inserts) and of the tumor suppressor p21 (p21C; 24-mer, KRRQTSMT
selected according to both the fluorescent intensity of DFYHSKRRLIFSKRKP), a peptide previously shown to
DiI and resistance to infection with DT- virus (see Ex- have a significant antiproliferative effect [12]. GFP-fused
perimental Procedures). The infection efficiency of the p21C-infected cells show higher DiI fluorescence in the
library was estimated at 10% based on GFP fluores- GFP-positive versus -negative population. Similarly, cells
infected with retroviruses encoding each of the fourcence. After two rounds of DT- virus selection and DiI-
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Figure 1. Isolation of the Peptides that Inhibit
Tumor Cell Growth
(A) Flow chart for growth inhibitory peptide
screening. 4  108 A549.tTA cells were in-
fected with TRA-GFP-C20 and selected for
resistance against infection of DT- virus and
fluorescent intensity of DiI (see Experimental
Procedures). During two rounds of DT- se-
lection and cell sorting, peptide expression
was on (Dox). Following bulk selection,
1.1  105 cells were plated for single-cell
cloning and peptide expression was sup-
pressed (Dox). 95 clones that showed both
reduction of cell growth in the absence of
Dox and normal cell growth in presence of
Dox were identified from 4128 clones initially
selected. The retroviral DNA inserts encoding
peptides were recloned and transduced into
naive A549.tTA cells to confirm their antipro-
liferative effect based on the fluorescent in-
tensity of DiI.
(B) Nucleotide and amino acid sequences of
35, 38, 40, and 41. The amino acid sequences
and in-frame stop codons in each peptide are
indicated as bold letters. The vector se-
quence is underlined.
peptides recovered from the screen (35, 38, 40, and 41) Cells infected with either 38 or 41 appeared to be ar-
rested in G0/G1 because cells in the S and G2/M phasesexhibited higher DiI fluorescence in the GFP-positive
population, indicative of their inhibition of cell prolifera- were significantly reduced. Cells infected with either 35
or 40 showed no significant change in the DNA contenttion. Furthermore, the antiproliferative effect (mainte-
nance of DiI staining intensity) of each of the four pep- profile. None of the GFP-fused peptides induced mas-
sive cell death as assessed by either direct observationtides was more pronounced in the highly GFP-positive
subpopulation, indicating that their activity is dose de- or appearance of a sub-G1 population (data not shown).
Because the peptides active in the functional screenpendent. Based on the intensity of GFP fluorescence,
two of the peptides (35 and 40), appeared to be ex- were fused to GFP, we sought to study their localization
in A549.tTA cells using confocal microscopy (Figure 3A).pressed at 10-fold lower levels than the other two pep-
tides, suggesting that they may represent more potent The four antiproliferative peptides were predominantly
localized to the cytoplasm, while dsGFP alone or aninhibitors of proliferation. All four peptides had a similar
antiproliferative effect in HeLa cells (cervical carcinoma inactive peptide (10, data not shown) was detected in
both the cytoplasm and the nucleus. Of the four antipro-cells, p53 deficient), Colo205 cells (colon cancer cells,
p53 mutant), H1299 (lung cancer cells, p53 null), MCF7 liferative peptides, three (38, 40, and 41) were concen-
trated both at the plasma membrane and in association(breast cancer cells, p53 wild-type), and normal human
mammary gland epithelial cells (p53 wild-type) (data not with cytoplasmic granular structures, while the majority
of the fourth peptide (35) was localized to cytoplasmicshown).
The effects of the four peptides on the cell cycle of granules but not to the plasma membrane. Peptides 35
and 38, and to a lesser extent peptide 41, exhibitedA549.tTA cells were also analyzed (data not shown).
Cells expressing each peptide or dsGFP were stained nuclear exclusion.
A colocalization study was performed with GFP-fusedwith Hoechst 33258 to allow estimation of DNA content.
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Figure 2. Cell Tracker Assay for Four Antiproliferative Peptides, 35, 38, 40, and 41
Fluorescent intensity of GFP and DiI in A549.tTA cells expressing peptides 35, 38, 40, 41, 10 (inactive peptide), dsGFP, or C-terminal peptide
of the CDK inhibitor p21 was analyzed using flow cytometry. DiI intensity of GFP-positive population (solid line), GFP high population (dashed
line), and GFP-negative population (dotted line) is shown as histograms (middle, right). Gates for the three populations are indicated in the
GFP histograms (left).
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Figure 3. Cytoplasmic Localization of Four
Antiproliferative Peptides
(A) Cellular localization of GFP-fused pep-
tides 35, 38, 40, and 41. A549.tTA cells ex-
pressing GFP-fused peptides 35, 38, 40, and
41 were plated on coverslips and analyzed
with a confocal scanning microscope (Leica
Mycrosystems, Inc., Bannockburn, IL).
(B) Localization of clathrin and GFP-fused
peptides. A549.tTA cells expressing peptides
38 or 41 were costained with anti-GFP anti-
body and anti-clathrin antibody or anti-vin-
culin antibody. Images were observed by a
fluorescent microscopy. The optical sections
were acquired through the green and red
channels for GFP and clathrin, respectively.
peptides 38 and 41. Both peptides had a similar localiza- with exportin-1 and localization of the peptide was resis-
tant to the exportin 1 inhibitor Leptomycin B (data nottion to the plasma membrane (most pronounced at cell-
cell contact areas) and to cytoplasmic granular structures. shown).
We examined costaining with several membrane- and
cytoskeleton-localized proteins. Our analysis revealed Mutational Analysis of Peptide 38
Peptide 38 contains a carboxy-terminal CAAX box motifthat clathrin, which also localizes to the plasma mem-
brane and cytoplasmic granular structures, overlaps that typically serves as a signal for posttranslational
prenylation and results in membrane attachment of thewith the localization of peptides 38 and 41 (Figure 3B).
We did not see colocalization of peptides 38 and 41 prenylated protein product [17–19]. In the prenylation
reaction, a 15 carbon farnesyl or 20 carbon geranylgera-with mitochondrial markers, Golgi markers, actin, tublin,
annexin II, vinculin, plakoglobin, desmoplakin, Ras, or nyl isoprenoid is attached to the CAAX motif Cys residue
by a farnesyl transferase or geranylgeranyl transferase,transferrin-labeled granules (data not shown except for
vinculin). Although peptide 41 contained a leucine-rich respectively. Interestingly, the carboxy-terminal half of
peptide 38 is nearly identical to the 17 carboxy-terminalmotif associated with nuclear exclusion mediated by
exportin 1 (see below), we did not observe colocalization residues of cell division cycle 42 isoform 2, (CDC42C;
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Figure 4. Amino Acid Sequences of GFP-
Fused Peptides 35, 38, 40, 41 and Their
Mutants
Mutated residues or nonidentical residues
of the C terminus of cell division cycle 42
isoform 2, CDC42C, (amino acids 175–191,
gi|16357472|ref|NP_426359.1|) to 38 are un-
derlined. Amino acid sequences of 35, 40, and
41 are aligned with leucine-rich motifs of
HIV-1 Rev (amino acids 75–84, gi|16118296|-
gb|AAL12672.1|), HTLV-1 Rex (amino acids
82–93, gi|7963889|gb|AAF71372.1|), mitogen-
activated protein kinase kinase 1, MAPKK,
(amino acids 33–43, gi|5579478|ref|NP_002-
746.1|), human homolog of mouse double mi-
nute 2, Hdm-2, (amino acids 189–200,
gi|4505137|ref|NP_002383.1|), and protein ki-
nase inhibitor, PKI (amino acids 38–48, gi|20-
3271|gb|AAA40867.1|).
Figure 4) (gi|16357472|ref|NP_426359.1|), a Rho-family antiproliferative activity while alanine point mutants
within the first 8 residues of peptide 38 exhibit either aGTPase that has been shown to be geranylgerany-
lated [20]. reduced (L4A, L5A, K6A, L7A) or enhanced (T1A, S2A)
cell proliferation phenotype. A portion of the membraneTo investigate the relative importance of the CAAX
motif and other sequence elements within peptide 38, localization of peptide 38 may also be provided by non-
CAAX elements since deletion of all but the CCIS se-we evaluated the localization and antiproliferative activ-
ity of a variety of peptide 38-derived deletion and alanine quence (N1-13) reduced membrane association while
the K6A point mutant displayed enhanced granular andpoint mutants (Figure 4). As shown in Figures 5A and
5B, mutation of the CAAX motif Cys residue to Ala (C14A) reduced plasma membrane localization. The GFP fluo-
rescence intensity of all GFP-fused peptide 38 mutantsresulted in loss of both antiproliferative activity and
plasma membrane/granular localization. Furthermore, was similar to that of the wild-type peptide (data not
shown). Together, these observations indicate that thealthough all peptides retaining an intact CAAX motif
(including GFP-CDC42 peptide) exhibited at least some antiproliferative activity of peptide 38 requires both an
intact carboxy-terminal CAAX motif for membrane local-plasma membrane/granular localization similar to wild-
type peptide 38, only a subset of peptide 38 mutants ization as well as critical sequence elements within the
first 8 amino acids at the amino terminus.demonstrated an antiproliferative phenotype. These ob-
servations indicate that the CAAX motif is (i) necessary To further evaluate the proposed importance of pep-
tide 38 prenylation for membrane localization, A549.tTAand sufficient for membrane localization and (ii) neces-
sary but not sufficient for antiproliferative activity. An cells expressing peptides 38 and 41 (a peptide lacking
the CAAX motif) were treated with a peptidomimeticadditional important contribution to the antiproliferative
activity of peptide 38 is made by amino-terminal se- farnesyltransferase specific inhibitor, L-744,832, for 48
hr. As shown in Figure 5C, membrane localization ofquence components. Deletion of the amino-terminal half
of peptide 38 (N1-8), leaving the carboxy-terminal CCIS peptide 38, but not 41, was completely abolished in the
presence of 2 M L-744,832, indicating that localizationand localization intact, results in a strong reduction of
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Figure 5. Mutational Analysis of Peptide 38
(A) A549.tTA cells were infected with retrovi-
ruses encoding GFP-fused peptides (38 and
its mutants) and stained with the cell tracker
dye, DiI. Fluorescent intensity of GFP and DiI
was examined by flow cytometry. A “fold inhi-
bition” of proliferation was determined by
the ratio of mean DiI fluorescent intensity for
the GFP-positive population relative to that
of the GFP-negative population. Fold inhibi-
tion is shown as mean  SE in duplicate. As
controls, the entire GFP-fused peptide li-
brary, dsGFP- and GFP-fused p21C-express-
ing A549.tTA cells were used.
(B) Localization of GFP-fused peptides was
examined by fluorescence microscopy. The
images were captured with a CCD camera.
(C) Farnesyltransferase-dependent localiza-
tion of 38. A549.tTA cells expressing 38 and
41 were plated on coverslips and incubated
with 2 M L-744,832 for 48 hr () or without
L-744,832 (). Localization of GFP-fused
peptides was examined by flourescence mi-
croscopy and images were captured with a
CCD camera.
of peptide 38 is farnesyltransferase dependent. Consis- acterized by three leucines separated by 2–3 other resi-
dues, and a fourth leucine separated by a single residue.tent with the reported geranylgeranyl modification of
CDC42 [20], localization of the 17 carboxy-terminal resi- These motifs are reported to mediate nuclear exclusion
through recognition and transport out of the nucleus bydues of the CAAX box peptide from CDC42 (CDC42C)
was unaffected by L-744,832 (data not shown). a complex including exportin-1 [21–23].
To evaluate the importance of the leucine-rich se-
quence motifs for the localization and the antiprolifera-Mutational Analysis of Peptides 35, 40, and 41
In contrast to peptide 38, peptides 35, 40, and 41 are tive effects of peptides 35, 40, and 41, alanine mutants
were constructed at one or more of the positions occu-significantly enriched for arginine and hydrophobic amino
acids such as leucine, isoleucine, methionine, and phe- pied by hydrophobic residues within the motif. Single,
double, and triple mutants were constructed for eachnylalanine relative to 41 peptides randomly picked from
the library or the theoretical occurrence of these amino peptide (corresponding to positions 4, 34, and 234
in the motif; see Figure 4). Each mutant was evaluatedacids based on codon frequency (data not shown). Inter-
estingly, the sequence of peptides 35, 40, and 41 could for antiproliferative activity in the DiI staining intensity
assay and for GFP localization by fluorescence micros-be aligned with a leucine-rich motif found in HIV-1 Rev,
HTLV-1 Rex, mitogen-activated protein kinase kinase 1 copy (Figure 6). For peptides 40 and 41, single, double,
and triple mutants exhibited progressively reduced lo-(MAPKK), human homolog of mouse double minute 2
(Hdm-2), and protein kinase A inhibitor (PKI), when other calization at the plasma membrane and granular cyto-
plasmic structures, and antiproliferative activity. The ef-hydrophobic residues such as isoleucine, methionine,
phenylalanine, and tryptophan are allowed to replace fects on proliferation appeared to be more pronounced
with peptide 41 mutants. However, it is difficult to deter-some leucines (Figure 4). This leucine-rich motif is char-
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Figure 6. Mutational Analysis of Peptides 35,
40, and 41
(A) A549.tTA cells expressing GFP-fused
peptides (35, 40, 41, and their mutants) were
stained with DiI. Fluorescent intensity of GFP
and DiI was examined by flow cytometry. A
fold inhibition of proliferation was obtained
as described above (Figure 5, legend). Fold
inhibition is shown as meanSE in duplicate.
As controls, the entire GFP-fused peptide li-
brary, dsGFP- and GFP-fused p21C-express-
ing A549.tTA cells were used.
(B) Localization of GFP-fused peptides was
examined by fluorescence microscopy. The
images were captured with a CCD camera.
mine the precise correlation between sequence, local- erative activity are poorly correlated. Furthermore, the
role of the leucine-rich motif in maintaining nuclear ex-ization, and antiproliferative activity due to the nonquan-
titative nature of fluorescence microscopy and the clusion appears to be less critical for peptide 35 relative
to peptides 40 and 41.observation that the mutant peptides were expressed
at higher levels (based on GFP intensity) relative to the In order to examine whether the GFP protein scaffold
is required for the antiproliferative effect of the peptideswild-type peptides (2-fold for peptide 40 and 2- to
10-fold for peptide 41) (data not shown). For peptide identified in our genetic screen, we synthesized peptides
40 and 41 (and corresponding mutants in which the leu-35, the single (I18A) and double (L16A/I18A) mutants
retained localization to cytoplasmic membranes and nu- cine-rich motif was replaced with four alanines; shown
in Figure 7A). Because polybasic peptides can be effi-clear exclusion similar to the wild-type peptide, while
the triple mutant (I12A/L16A/I18A) exhibited reduced ciently internalized by cells [24–26], the peptides were
fused with 7 Lys residues (K7) via a linker (GGEEAAKA)membrane association and nuclear exclusion. In addi-
tion, cells expressing L16A/I18A or I12A/L16A/I18A lost at their amino terminus (K7_40, K7_40M, K7_41, and
K7_41M). FITC-labeled versions of the synthetic pep-their antiproliferative effect. The fluorescence intensity
of all GFP-fused peptide 35 mutants was similar to that tides were also used for localization studies. The fluores-
cent peptides localized not only to the plasma mem-of the wild-type peptide (data not shown). These results
with peptide 35, most notably the double mutant L16A/ brane and cytoplasm but also to the nucleus, indicating
efficient uptake of these peptides by the cells (data notI18A, indicate that subcellular localization and antiprolif-
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Figure 7. Evaluation of Synthetic Peptides
(A) Synthetic peptides 40 and 41 and their
mutant sequences. The peptides were fused
with seven Lys (K7) via a linker (GGEEAAKA)
at the amino terminus (K7_40, K7_40M, K7_41,
and K7_41M).
(B) Displacement of GFP localization with
synthetic peptides. A549.tTA cells express-
ing GFP-fused peptide 41 were plated on
coverslips and incubated with 100 M of
K7_41, K7_41M, K7_40, or no peptide for 5
hr, and GFP localization was analyzed by flu-
orescence microscopy. The images were
captured with a CCD camera.
(C) Antiproliferative effect of synthetic pep-
tides. A549 cells were incubated with pep-
tides K7_40, K7_40M, K7_41, and K7_41M at
a final concentration ranging from 0.8 to 25
M in triplicate for 24 hr. The number of nuclei
in each well was counted using a Zeiss Axio-
vert microscope, UV filter set, and Photomet-
rics camera. The number of nuclei was nor-
malized to that of untreated samples and is
shown as % mean (symbol)  % SD (bar).
The mean percentage of nuclei is indicated
as relative cell number in the graph. Open
square, K7_40; closed square, K7_40M; open
circle, K7_41; closed circle, K7_41M.
shown). Because of the nature of polybasic peptides cell contact area, we examined whether K7_41 could
displace membrane localization of the GFP-fused pep-[24, 25], they were predominantly transported to the
nucleus and nucleoli. We did not see a significant differ- tides. A549.tTA cells expressing GFP-fused peptide 41
were incubated with 100 M of K7_41, K7_41M, andence in the localization of the K7_40 and K7_41 peptides
or between the wild-type and mutant peptides. K7_40 for 5 hr and GFP localization was analyzed using
fluorescence microscopy (Figure 7B). A549 cells ex-If these synthetic peptides interact with the same
protein target as the GFP-fused peptides, they should pressing GFP-fused peptide 41 treated with K7_41 pep-
tide showed more pronounced cytoplasmic granular lo-compete for cellular localization with the GFP-fused
peptides. Because GFP-fused peptides 38 and 41 were calization of GFP and loss of GFP localization in the
cell-cell contact area. Importantly, these changes insimilarly concentrated at the plasma membrane and
granular cytoplasmic structures, especially at the cell- GFP peptide 41 localization were not observed in cells
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treated with K7_41M or K7_40. Surprisingly, similar Peptide 38 has a functional CAAX box motif at its
carboxyl terminus; membrane localization is disruptedchanges were observed when A549.tTA cells expressing
GFP-fused peptide 38 were cultured with K7_41, but not by mutation of the critical Cys residue or upon addition
of a farnesyl transferase inhibitor. Notably, deletion ofK7_41M or K7_40 (data not shown). These results indi-
cate that K7_41 specifically perturbs the plasma mem- the amino-terminal 13 residues of peptide 38 (leaving
only the CAAX motif) also alters its localization. Thus,brane localization of GFP-fused peptides 41 and 38.
In order to determine whether the synthetic peptides peptide 38 is most likely anchored to cellular mem-
branes by prenylation via a mechanism that is, in part,directly affected cell proliferation, A549 cells were treated
with K7_40, K7_40M, K7_41, and K7_41M for 24 hr. The dependent on the presence of specific amino-terminal
residues in an adjacent basic region. The requirement ofcells were fixed and stained with the DNA dye DAPI and
the number of nuclei present in each well was quantified a similar basic region has been documented for plasma
membrane targeting of p21K-ras(B) [18]. Deletion of thewith an automated imaging method (as described in
Experimental Procedures). Both K7_40 and K7_41 elic- amino-terminal 8 residues of peptide 38 retains its mem-
brane localization, but not its DiI accumulation-basedited a dose-dependent decrease in the number of cells
with a midpoint concentration of 10–15M, while K7_40M antiproliferative activity, indicating that localization by
farnesylation is necessary but not sufficient for the ob-and K7_41M showed no significant reduction in cell
number (shown in Figure 7C). Together, these results served inhibition of cell growth. The K6A mutant also
showed changes in localization associated with a losssuggest that synthetic versions of the peptides isolated
in our functional genetic screen (appended with an inter- of antiproliferative activity, indicating this residue also
plays an important role in the localization and functionnalization sequence) can both displace the GFP-fused
functional peptides from their intracellular target(s) and of peptide 38. Taken together, GFP-fused peptide 38
likely exerts an antiproliferative effect through interac-mimic the effect of the GFP-fused peptides on cell prolif-
eration. tion with a target molecule(s) in the cell membrane rather
than by inhibiting a farnesyl transferase.
Interestingly, the antiproliferative effect of the GFP-
Discussion fused peptide 38S2A mutant was enhanced and exhib-
ited potency similar to that of the PCNA binding GFP-
In this paper, we have demonstrated the ability to iden- p21C. This may be due to the increased affinity or acces-
tify unique antiproliferative peptides from a random li- sibility of the peptide to the target protein. It is important
brary expressed in a human lung carcinoma cell line. to note that through systematic mutagenesis, one could
A FACS-based genetic selection scheme was devised optimize the peptide’s antiproliferative potency. Such
based on cell tracker dye (DiI) accumulation and cell an optimized peptide could be useful tool for validating
survival after infection of the toxic retrovirus. Incorpora- candidate target proteins.
tion of the tet-inducible system in our screen was also GFP-fused peptide 35-, 40-, and 41-derived alanine
a key element for identification of the peptides. Hence mutants were constructed and tested for both localiza-
we established a new approach to identify inhibitors of tion and function. Multiple mutations in the leucine-rich
cell proliferation, which was quite challenging. According motif resulted in loss of the antiproliferative effect and
to the nature of our screening, we expected to identify alteration of cellular localization. However, the effects
peptides that confer an antiproliferative phenotype but on antiproliferative activity did not always coincide with
do not exhibit cytotoxic effects. Indeed, all four peptides effects on cellular localization (particularly for peptide
recovered from the screen and characterized in the pres- 35). These results suggest that the leucine-rich motif
ent study were antiproliferative in the DiI accumulation may be involved in cellular localization to membrane
assay and did not induce cell death. Each of the GFP- structures or the plasma membrane and enhance the
fused peptides identified in this study showed an anti- antiproliferative effect by increasing the local concentra-
proliferative effect in p53 wild-type cells (MCF7, A549, tion of GFP-fused peptides. Peptide 40 and 41 exhibited
and normal human mammary epithelial cells), as well apparent nuclear exclusion by standard fluorescence
as p53-deficient cell lines (HeLa, Colo205, and H1299). microscopy (Figure 6B). However, confocal microscopy
Thus, this inhibition appears to be independent of p53 indicated that peptides 40 and 41 were not completely
status, and these peptides do not show an absolute nuclear excluded (Figure 3A) but are highly concentrated
distinction between tumor and normal cells. Interest- at the plasma membrane and cytoplasmic granular
ingly, the four antiproliferative peptides showed specific structures.
localization to the plasma membrane or granular cyto- Identification of the protein targets of the antiprolifera-
plasmic structures. One peptide (38) contains a CAAX tive peptides is a very important next step, because
box motif while the other three (35, 40, and 41) have the protein would be already validated as a target for
related leucine-rich motifs. Our deletion and alanine- antiproliferative drugs, whether or not the drugs were
scanning mutational analysis indicated that localization based on the peptides isolated from this screen. There
of the peptides is crucial for optimal antiproliferative are several advantages of this peptide-based approach.
activity and that the CAAX box and leucine-rich motifs (1) Since peptides can be expressed as GFP-fused pro-
play a key role in effective localization of the peptides. teins, colocalization study with antibodies against known
Importantly, synthetic analogs of two peptides (40 and molecules could be easily performed [8]. (2) Simple im-
41) exhibited dose-dependent antiproliferative effects munoprecipitation experiments using anti-GFP antibody
that were not observed with their corresponding mutant could isolate candidate target proteins [12]. (3) Ease of
procuring synthetic peptides and their immobilizationpeptides.
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on beads could allow us to perform affinity extraction Functional genetic screening approaches represent
of target proteins from cell extracts and their identifica- an efficient means for identifying and validating novel
tion via recent state-of-the-art proteomics strategies small peptide inhibitors. Several methods for “present-
[12, 27]. (4) Gain-of-function mutants and loss-of-func- ing” peptide libraries have been described, including
tion mutants are easily identified. These mutants could the production of linear scaffold-peptide fusions as in
functionally verify target proteins. We also developed a the present study and methods that constrain the pep-
novel method to identify the functional protein targets tide structure. Constraining peptides by tethering both
of active peptides using a yeast two-hybrid (YTH) ap- ends within the structure of a larger protein reduces the
proach recently (T. Kinsella, E. Masuda, M.K.B., B.H., J. entropic cost of binding, thus improving the chance of
Warner, T. Kinoshita, A. Martinez, and P. Achacoso, isolating a high-affinity interactor. In this context, we
unpublished data). Currently three approaches, immu- have recently exemplified this concept of constrained
noprecipitation, affinity extraction, and YTH, are under- random peptide libraries delivered by retroviral vectors
way in order to find the target proteins [4, 5, 8]. Furthermore, as a proof-of-concept we have
Because GFP-fused peptides 38 and 41 were local- successfully delivered random cyclic peptide libraries
ized to the plasma membrane and cytoplasmic granule utilizing retroviral technology and recently demonstrated
structures, we tested several membrane-associated that functional cyclic peptides can be identified as inhib-
proteins for colocalization. We found that GFP-fused 38 itors of IL-4 receptor-mediated signaling cascade [7].
and 41 colocalized with clathrin, but not other membrane However, the use of constrained peptide libraries may
associated markers. Clathrin is a major protein compo- prevent binding to potentially important targets owing
nent of coated vesicles and coated pits located on the to the decreased internal flexibility of the peptides. It is
cytoplasmic face of intracellular membrane structures noteworthy that increased flexibility affords more struc-
[28–31]. These specialized structures are involved in the tural variability, thus increasing the probability of identi-
intracellular trafficking of receptors and endocytosis of fying a conformational state capable of interacting with a
a variety of macromolecules. The antiproliferative effect target structure. As an example, a 20 amino acid peptide
of GFP-fused peptides 38 and 41 may be a result of derived from the C terminus of the cell cycle inhibitor
their role in altering the constitutive trafficking process p21 (p21C) inhibits in vitro replication of simian virus 40
of a variety of transmembrane proteins. DNA and binds to PCNA in whole-cell extracts [14].
The synthetic peptides K7_40 and K7_41, but not their Intracellular expression of p21C fused to the C terminus
corresponding mutants, K7_40M and K7_41M, clearly
of GFP also binds PCNA and induces a potent cell cycle
induced a dose-dependent inhibition of cell prolifera-
arrest [12, 13]. Thus, as exemplified by the present study,
tion. This indicated that the GFP protein scaffold is not
a GFP-fused peptide library is a viable method to identifyrequired for the antiproliferative effect of the peptides,
functional linear peptide inhibitors. An important advan-suggesting that a GFP-peptide library can be effectively
tage of the random peptide screening strategy is thescreened to isolate such peptides. FITC-labeled version
novelty of the sequences that are isolated. Such novelof both the wild-type and mutant peptides displayed
sequences represent unique tools to probe importantplasma membrane, and perinuclear and nuclear local-
disease-relevant signaling pathways and have the po-ization. These results suggest that the synthetic pep-
tential, particularly in the case of cyclic peptides, totides are effectively internalized through the cell mem-
serve as starting points for the development of peptide-brane and do not require the GFP scaffold for their
derived therapeutics. Since peptides could serve as aantiproliferative effect. However, we did not observe a
starting point of small molecule drugs, further studiessignificant difference in the localization of the wild-type
including identifying the minimal antiproliferative pep-and the mutant, suggesting that these peptides bind
tides via truncation analysis and obtaining more potentseveral targets not related to their antiproliferative ef-
peptides by introducing nonnatural amino acids wouldfect. This nonfunctional target binding may be attributed
be very important.to the hepta-lysine sequence. Hence, localization of flu-
orescently labeled K7_40 and K7_41 is distinct but over-
lapping with that of the corresponding GFP-fused pep-
Significancetides. Importantly, the K7_41 synthetic peptide displaced
the plasma membrane localization of GFP-fused pep-
The creation of diverse biomolecule libraries and anal-tides 41 and 38, while the displacement was not ob-
ysis of their effects on cell physiology is a powerfulserved in cells treated with K7_41M or K7_40. These
approach to elucidating important signaling pathwaysresults indicate that (i) K7_41 interacts with the same
in normal and diseased cells. Libraries of randomlytarget(s) as GFP-fused peptide 41 and likely exerts its
generated peptide sequences represent a vast sourceantiproliferative effect by virtue of this interaction, and
of novel structural entities. Large peptide libraries can(ii) that GFP-fused peptides 38 and 41 may function
be efficiently delivered and expressed in mammalianthrough common target molecules or may be closely
cells by retroviral vectors. Cells expressing random,related in a common pathway suppressing cell growth.
free, or constrained peptide structures can be screenedThe prospect that peptides 38 and 41 act by similar
for specific peptide-induced phenotypes. We gener-mechanisms is further supported by the fact that GFP-
ated a random peptide library fused to the C terminusfused 38 and 41 were concentrated similarly at the
of GFP and sought to identify peptides that can inhibitplasma membrane (especially at areas of cell-cell con-
the growth of lung carcinoma cells. A novel FACS-tact) and colocalized with clathrin, and that overexpres-
based genetic screen was devised to effectively enrichsion of both GFP-fused peptides showed accumulation
of cells at G0/G1. for nonproliferating cells, through detection of nondi-
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was determined as the ratio of mean DiI fluorescent intensity forviding cells with the cell tracker dye, DiI, and reduction
the GFP-positive population to that of the GFP-negative population.of cycling cells by infection with retrovirally encoded
diphtheria toxin  chain. Four unique peptide se-
Immunohistochemical Stainingquences were isolated that exhibited antiproliferative
A549.tTA cells expressing GFP-fused peptides 38 and 41 were
effects in several cell types. These peptides demon- plated on coverslips, washed with phosphate buffer saline, PBS,
strated specific localization to the plasma membrane and fixed in 50% methanol and 50% acetone for 5 min. Cells were
and cytoplasmic granular compartments. One peptide then washed twice with PBS, incubated with PBS containing 0.5%
saponine and 0.5% BSA for 20 min. After washing cells with PBScontained a CAAX box motif, which is important for its
twice, cells were incubated in PBS containing 0.5% saponine andmembrane localization and growth inhibitory activity.
0.5% BSA at room temperature for 1 hr with goat anti-clathrin heavyThree other peptides contained a leucine-rich motif,
chain antibody (Sigma) or mouse anti-vinculin antibody (Transduc-
similar to a known nuclear exclusion motif. Mutational tion laboratories), washed intensively, and then incubated with the
analysis revealed critical residues in each of the pep- secondary Alexa FluorR 546-labeled donkey anti-goat IgG antibody
tide sequences and demonstrated a correlation be- (Molecular Probes) or Alexa FluorR 546-labeled goat anti-mouse IgG
antibody (Molecular Probes), and Alexa FluorR 488-labeled rabbittween peptide subcellular localization and antiprolifer-
anti-GFP antibody (Molecular Probes). Both primary and secondaryative activity. Synthetic analogs of the peptides with
antibody solutions were precleared by centrifugation. After staining,poly-lysine internalization sequences, but not loss-
the coverslips were mounted in Fluoromount-G (Fisher Scientific,
of-function mutants, competed for subcellular local- Pittsburgh, PA). The samples were examined on a fluorescent micro-
ization of the GFP-scaffolded peptides. The synthetic scope, Axiovert S100 (Carl Zeiss MicroImaging, Inc., Thornwood,
peptides exhibited dose-dependent antiproliferative NY), equipped with a 63 A˚ 1.4 numerical aperture oil immersion
objective lens and the single fluorochrome filter sets for either Texaseffects on tumor cell lines, while mutant peptides had
red or fluorescein were used for visualization and recording of theno effect. Our results demonstrate that screening ret-
images. The images were captured with a CCD camera, modelrovirally expressed random peptides can identify unique
C4742-95-12ER (Hamamatsu Photonics K.K., Hamamatsu, Japan)
peptide sequences that affect specific biological func-
tions and thereby facilitate the development of novel Poly Lysine and FITC-Labeled Synthetic Peptides
therapeutics. Synthetic peptides fused with seven Lys (K7) via a linker (GGEEAAKA)
at the N terminus (K7_40, K7_40M, K7_41, K7_41M, K7_41_FITC,
and K7_41M_FITC) were purchased from New England Peptide Inc.,Experimental Procedures
Fitchburg, MA and American Peptide Company, Sunnyvale, CA.
Screening of GFP-Fused C Terminus
High-Content Imaging of Antiproliferative Peptides20-mer Random Peptide Library
A549 cells (American Type Culture Collection [ATCC], Manassas,A retroviral peptide library consisting of a random 20-mer peptide
VA) were plated at 2000 cells/well in 96-well plates with F12K mediawith a linker (EEAAKA) fused at the C terminus of GFP in a tetracy-
supplemented with 10% fetal bovine serum and 1% penicillin/strep-cline (tet)-regulatable (tet-off system) retroviral vector, TRA, [32] was
tomycin and allowed to grow for 24 hr. Peptide dissolved in mediaconstructed as previously reported (TRA-GFP-C20) [8]. Transfection
was added to the cells to a final concentration ranging from 0.8 toof the library into an amphotropic retrovirus packaging cell line,
25 M in triplicate. Following incubation with peptide for 24 hr, cellsφNX-Ampho, which produces infectious retrovirus up to 5  106
were fixed with 3.7% formaldehyde for 30 min, rinsed in PBS, andinfectious U/ml was carried out as described previously [33]. Tetra-
stained with DAPI (Molecular Probes) to label nuclear DNA. Digitalcycline-regulatable transactivator (tTA)-expressing lung tumor cells,
images of the labeled nuclei in each well were obtained using aA549.tTA [32], were spin infected with the supernatant from φNX-
Zeiss Axiovert microscope, UV filter set, and Photometrics camera.Ampho cells at 2500 rpm for 1.5 hr at 32C and were incubated for
Images were analyzed using the Image Pro software package to12 hr at 32C. Cells were then incubated at 37C for 24 hr to allow
count the number of nuclei.integration and expression of the retrovirus. Cells were then stained
with a cell tracker dye, 5 M DiI (D-282, Molecular Probes, Inc.,
Eugene, OR), for monitoring proliferation as per manufacturer’s rec- Acknowledgments
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